Viking Therapeutics (VKTX) Consolidated Net Income (2014 - 2026)
Viking Therapeutics (VKTX) posted Consolidated Net Income of -$132.6 million for Q2 2026, compared with -$74.57 million a year earlier.
Powered by 
Analysis
Viking Therapeutics (VKTX) Consolidated Net Income (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Viking Therapeutics was -$560.02 million; for FY2025, it came in at -$393.34 million.
- In prior years, Viking Therapeutics' Consolidated Net Income was -$150.92 million in FY2024, -$100.83 million in FY2023, -$70.36 million in FY2022 and -$55.68 million in FY2021.
- Quarterly Consolidated Net Income has run from a low of -$164.74 million in Q4 2025 to a high of -$12.51 million in Q4 2021 over five years.
- According to Business Quant data, Consolidated Net Income for the three prior quarters was -$164.13 million (Q1 2026), -$164.74 million (Q4 2025) and -$98.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.96 Bn | 1,098.54 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 635.65 Bn | 555.51 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 504.89 Bn | 478.00 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 358.50 Bn | 312.87 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 291.04 Bn | 255.03 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.27 Bn | 238.95 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.76 Bn | 193.16 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 195.00 Bn | 169.20 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.37 Bn | 118.02 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Viking Therapeutics | 2.85 Bn | 323.73 Mn | - | -132.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -132.60 Mn |
| Mar 31, 2026 | -164.13 Mn |
| Dec 31, 2025 | -164.74 Mn |
| Sep 30, 2025 | -98.56 Mn |
| Jun 30, 2025 | -74.57 Mn |
| Mar 31, 2025 | -55.47 Mn |
| Dec 31, 2024 | -46.24 Mn |
| Sep 30, 2024 | -36.56 Mn |
| Jun 30, 2024 | -34.05 Mn |
| Mar 31, 2024 | -34.07 Mn |
| Dec 31, 2023 | -29.29 Mn |
| Sep 30, 2023 | -27.27 Mn |
| Jun 30, 2023 | -23.74 Mn |
| Mar 31, 2023 | -20.54 Mn |
| Dec 31, 2022 | -20.28 Mn |
| Sep 30, 2022 | -16.20 Mn |
| Jun 30, 2022 | -17.63 Mn |
| Mar 31, 2022 | -16.25 Mn |
| Dec 31, 2021 | -12.51 Mn |
| Sep 30, 2021 | -13.40 Mn |
API Access
Viking Therapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();